Our Mission:
Develop innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases.

The premier biotherapeutic targeting company

Our powerful AbiLeap™ discovery engine combines massively parallel, continuously learning AI with an extensive database of antigen-antibody interactions to generate fully human, IgG-based multispecific antibodies of exquisite selectivity and affinity. The antibodies respond to environmental signals within the cellular microenvironment, generating logic-gated therapeutics.

We are dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need. 

Biotechnology

Life Sciences

Pharmaceutical

Ability Biologics

Ability Biologics' headquarters in Montreal, Canada

This department focuses on the development and innovation of platform technologies and solutions.

Platform Sciences

This department provides strategic direction and oversight for the entire organization.

Executive Leadership

This department focuses on scientific research and innovation to develop new products and solutions.

Research and Development

This department provides expert guidance and strategic advice in scientific and technical areas.

Advisory Board

This department oversees the planning and execution of development and translation initiatives.

Development & Translation

This department oversees financial asset management and investment strategies to optimize returns.

People (2)

Jobs (0)

Other teams

Executive Leadership

Research and Development

Advisory Board

Development & Translation

Investment Management